A Study to Assess the Safety of RG6496 in Huntington’s Disease Gene Expansion Carriers with the Selected Genetic Variant (POINT-HD)
BP45378
Phase 1 other active
Quick answer
A Study to Assess the Safety of RG6496 in Huntington’s Disease Gene Expansion Carriers with the Selected Genetic Variant (POINT-HD) for Huntington’s Disease Gene Expansion Carriers is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Huntington’s Disease Gene Expansion Carriers
- Phase
- Phase 1
- Modality
- other
- Status
- active